This comprehensive webinar is part of the IBD Pro Webinar Series, focusing on the management of complicated Crohn’s disease cases. Speakers Edward Barnes, MD, MPH, and Katie Dunleavy, MB, BCh, BAO, host an in-depth discussion on pouchitis management.
Update on Pouchitis Management: Current Strategies and Emerging Therapies
Target Audience
This activity is intended for physicians, nurses, and all healthcare professionals engaged in the care of patients with inflammatory bowel disease (IBD).
Educational Objectives
After completing this activity, the participant should be better able to:
- Discuss current standards and protocols for managing pouchitis, including the use of antibiotics, probiotics, and other conservative treatment methods.
- Describe the indications, benefits, and limitations of these established therapies in the routine care of pouchitis patients.
- Explore the latest advancements and innovative treatments under development for pouchitis, such as novel biologics and targeted therapies.
- Translate recent research findings into practical strategies for pouchitis management.
- Explain case studies or clinical scenarios to demonstrate how new research can be applied to improve treatment outcomes.
Method of Participation and Request for Credit
In order to obtain your CE certificate, please follow the steps below at the conclusion of the activity:
- Go to www.cmeuniversity.com
- Login or Create a New Account (will take less than 1 minute)
- If you receive a message when creating a new account that “the email you entered is already in use”, please click the forgot my username or password link to have your Username and Password sent to you via email
- After logging in, you may be asked to verify/update your information; after doing so, click Save at the bottom of the page
- Type in 18165 at the top of the page, “Find Post-Test/Evaluation by Course”, and click enter
- Click on the activity title when it appears
- Choose the type of credit you desire
- (If applicable) Complete the Post-test with a passing score of 75% or better
- Complete the online Evaluation
- Receive an immediate CE Certificate to download and/or print for your files
For Pharmacists: Upon successfully completing the post-test with a score of 75% or better (if applicable) and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service.
If you have questions regarding the certification of this activity, please contact PIM via email at inquiries@pimed.com.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Crohn’s & Colitis Foundation. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hours.
Continuing Pharmacy Education
Postgraduate Institute for Medicine designates this continuing education activity for 1.0 contact hour(s) (0.1 CEUs) of the Accreditation Council for Pharmacy Education.
(Universal Activity Number - JA4008162-9999-24-480-H01-P
Type of Activity (select one): Application
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
System Requirements
- Supported Browsers (2 most recent versions):
- Google Chrome for Windows, Mac OS, iOS, and Android
- Apple Safari for Mac OS and iOS
- Mozilla Firefox for Windows, Mac OS, iOS, and Android
- Microsoft Edge for Windows
- Recommended Internet Speed: 5Mbps+
Publication Dates
Release Date:
Expiration Date:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Recommended
David A. Schwartz, MD
Ira Leeds, MD, FACS, FASCRS